SELLAS Life Sciences Group Inc (NASDAQ: SLS) on Friday, soared 3.65% from the previous trading day, before settling in for the closing price of $3.84. Within the past 52 weeks, SLS’s price has moved between $0.85 and $5.18.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 45.94%. The company achieved an average annual earnings per share of 48.00%. With a float of $140.17 million, this company’s outstanding shares have now reached $142.44 million.
SELLAS Life Sciences Group Inc (SLS) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of SELLAS Life Sciences Group Inc is 1.60%, while institutional ownership is 23.74%. The most recent insider transaction that took place on Nov 19 ’25, was worth 100,806. In this transaction Director of this company bought 63,400 shares at a rate of $1.59, taking the stock ownership to the 104,400 shares. Before that another transaction happened on Jun 12 ’25, when Company’s Director bought 10,000 for $1.48, making the entire transaction worth $14,800. This insider now owns 20,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.08 earnings per share (EPS) for the period topping the consensus outlook (set at -0.11) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.75% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
SELLAS Life Sciences Group Inc (SLS) is currently performing well based on its current performance indicators. A quick ratio of 8.28 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.32 in one year’s time.
